1. Home
  2. PDFS vs PHAR Comparison

PDFS vs PHAR Comparison

Compare PDFS & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDF Solutions Inc.

PDFS

PDF Solutions Inc.

HOLD

Current Price

$41.32

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$17.75

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDFS
PHAR
Founded
1992
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
PDFS
PHAR
Price
$41.32
$17.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$33.67
$38.33
AVG Volume (30 Days)
318.7K
16.1K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$22.13
$10.04
Revenue Next Year
$18.92
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$16.63
$8.04
52 Week High
$41.03
$21.34

Technical Indicators

Market Signals
Indicator
PDFS
PHAR
Relative Strength Index (RSI) 73.34 62.36
Support Level $30.71 $17.25
Resistance Level N/A $18.30
Average True Range (ATR) 1.65 0.59
MACD 0.81 0.16
Stochastic Oscillator 91.99 84.95

Price Performance

Historical Comparison
PDFS
PHAR

About PDFS PDF Solutions Inc.

PDF Solutions Inc provides products and services designed to empower organizations across the semiconductor and electronics ecosystem to connect, collect, manage, and analyze data about design, equipment, manufacturing, and test to improve the yield and quality of their products and operational efficiency. The Company's products, services, and solutions include proprietary software, physical intellectual property (IP) for integrated circuit (IC) designs, electrical measurement hardware tools, methodologies, and professional services.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: